Revisiting MET: Clinical Characteristics and Treatment Outcomes of Patients with Locally Advanced or Metastatic, MET‐Amplified Esophagogastric Cancers

BACKGROUND: Metastatic esophagogastric cancers (EGCs) have a poor prognosis with an approximately 5% 5‐year survival. Additional treatment approaches are needed. c‐MET gene‐amplified tumors are an uncommon but potentially targetable subset of EGC. Clinical characteristics and outcomes were evaluated...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncologist
Main Authors: Chaudhary, Surendra Pal, Kwak, Eunice L., Hwang, Katie L., Lennerz, Jochen K., Corcoran, Ryan B., Heist, Rebecca S., Russo, Andrea L., Parikh, Aparna, Borger, Darrell R., Blaszkowsky, Lawrence S., Faris, Jason E., Murphy, Janet E., Azzoli, Christopher G., Roeland, Eric J., Goyal, Lipika, Allen, Jill, Mullen, John T., Ryan, David P., Iafrate, A. John, Klempner, Samuel J., Clark, Jeffrey W., Hong, Theodore S.
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley & Sons, Inc. 2020
Assuntos:
Gastrointestinal Cancer
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7648344/
https://ncbi.nlm.nih.gov/pubmed/32820577
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2020-0274
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados